Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
MUC17 is an essential small intestinal glycocalyx component that is disrupted in Crohn’s disease
Elena Layunta, … , Bruce A. Vallance, Thaher Pelaseyed
Elena Layunta, … , Bruce A. Vallance, Thaher Pelaseyed
Published December 19, 2024
Citation Information: JCI Insight. 2025;10(3):e181481. https://doi.org/10.1172/jci.insight.181481.
View: Text | PDF
Research Article Cell biology Gastroenterology

MUC17 is an essential small intestinal glycocalyx component that is disrupted in Crohn’s disease

  • Text
  • PDF
Abstract

Crohn’s disease (CD) is the chronic inflammation of the terminal ileum and colon triggered by a dysregulated immune response to bacteria, but insights into specific molecular perturbations at the critical bacteria-epithelium interface are limited. Here, we report that the membrane mucin MUC17 protected small intestinal enterocytes against commensal and pathogenic bacteria. In noninflamed CD ileum, reduced MUC17 levels and a compromised glycocalyx barrier allowed recurrent bacterial contact with enterocytes. Muc17 deletion in mice rendered the small intestine particularly prone to atypical bacterial infection while maintaining resistance to colitis. The loss of Muc17 resulted in spontaneous deterioration of epithelial homeostasis and in the extraintestinal translocation of bacteria. Finally, Muc17-deficient mice harbored specific small intestinal bacterial taxa observed in patients with CD. Our findings highlight MUC17 as an essential region-specific line of defense in the small intestine with relevance for early epithelial defects in CD.

Authors

Elena Layunta, Sofia Jäverfelt, Fleur C. van de Koolwijk, Molly Sivertsson, Brendan Dolan, Liisa Arike, Sara I.M. Thulin, Bruce A. Vallance, Thaher Pelaseyed

×

Figure 3

Deletion of Muc17 results in abnormal small intestinal susceptibility to C. rodentium infection.

Options: View larger image (or click on image) Download as PowerPoint
Deletion of Muc17 results in abnormal small intestinal susceptibility to...
(A) Infection protocol and sampling time points. Si5, jejunum; Si8, ileum; DC, distal colon. (B) C. rodentium CFU in fecal samples at various days postinfection (dpi). (C) Weight loss of infected Muc17fl/fl and Muc17ΔIEC mice as percentage of the initial weight at 0 dpi. (D) C. rodentium CFU in luminal compartments of Si5, Si8, and DC at 3 dpi. (E) C. rodentium CFU in mucosal compartments of Si5, Si8, and DC at 3 dpi. (F) C. rodentium CFU in mesenteric lymph nodes (MLNs), spleen, and liver at 7 dpi. Circle charts represent proportion of mice with CFU above the limit of detection (LOD) in each segment or tissue site. (G) Relative risk of carrying C. rodentium CFU above LOD in Si5, Si8, and DC luminal and mucosal compartments. n = 6–10 per group. (H) Relative risk of carrying C. rodentium CFU above LOD in MLNs, spleen, and liver. n = 6–10 per group. (I) Immunohistochemistry of C. rodentiumGFP+ (magenta) in relation to epithelium (EpCAM, green) in the Si5 of Muc17fl/fl and Muc17ΔIEC mice 3 dpi. Yellow arrows point to bacterial cells. Scale bar, 50 μm. (J) Immunohistochemistry of C. rodentiumGFP+ (magenta) in relation to epithelium (EpCAM, green) in the DC of Muc17fl/fl and Muc17ΔIEC mice 3 dpi. Yellow arrows point to bacterial cells. Scale bar, 50 μm. (K) Visualization of C. rodentiumGFP+ (magenta) in relation to epithelium (DNA, cyan) in explants of Muc17fl/fl and Muc17ΔIEC DC 3 dpi. Upper panels show top view (x,y plane) and lower panels show extended orthogonal view (x,z plane) of boxed region (orange). Penetration of C. rodentiumGFP+ (magenta) into colonic crypts (yellow dashed lines) is highlighted (yellow arrows). Scale bar, 100 μm. Significance was determined by Mann-Whitney test (D–F).

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts